Superworth

ICU Medical ICUI

Medical - Instruments & Supplies, Healthcare
$162.38
−0.85%
Market cap
$4.1B
PE
138×
10y median 57.9×
Forward PE
n/m
not a meaningful number
Price to sales
1.9×
EV/EBIT
44.9×
Revenue, 12 months
$2.2B
−9% on a year ago
Net margin
1.4%
Free cash flow yield
3.8%

ICU Medical trades at 138× trailing earnings, pricier than 82% of the last ten years. Revenue was $2.2B over the last twelve months, down 9% on a year earlier with a 1% net margin.

Charts

Financials

Income statement for ICUI, by quarter
Income statementQ3 FY23Q4 FY23Q1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
$553.3M−8%$587.9M+2%$566.7M−0%$596.5M+9%$589.1M+7%$629.8M+7%$604.7M+7%$548.9M−8%$537M−9%$540.7M−14%$530.2M−12%$551.7M+1%
Cost of revenue$369.4M−10%$416.3M+3%$381.4M+1%$389M+9%$384.3M+4%$402.5M−3%$394.6M+4%$340.8M−12%$336.1M−13%$337.7M−16%$324M−18%$316.6M−7%
Gross profit$183.9M−1%$171.6M−2%$185.2M−4%$207.4M+8%$204.9M+11%$227.3M+32%$210.1M+13%$208.1M+0%$200.9M−2%$203M−11%$206.2M−2%$235.1M+13%
R&D$20.9M−10%$22.4M−4%$21.8M+11%$23.4M+5%$21M+1%$22.4M−0%$23.3M+7%$21.9M−7%$21.3M+1%$21.1M−6%$21.3M−9%$22.7M+4%
SG&A$148.6M−3%$154.6M+8%$157.7M+3%$159.5M+6%$162.7M+10%$158.8M+3%$157.2M−0%$159.4M−0%$152.8M−6%$155.8M−2%$154.6M−2%$151.9M−5%
$22.9M−$12.2M+5388%−$10.7M$7.7M+179%$8.2M−64%$37.7M$12.9M$10.6M+38%$13.7M+67%$5.6M−85%$13.6M+5%$39.1M+270%
Interest expense$24.2M+36%$31.9M+30%$23.8M+6%$23.8M−1%$24.7M+2%$34.2M+7%$22M−7%$20.5M−14%$19.8M−20%$30.9M−10%$16.5M−25%$15.7M−23%
Pre-tax income−$5.4M−75%−$36.7M+71%−$36.8M+175%−$19.5M−15%−$17.9M+234%$8.2M−$10.9M−70%$33.7M−$2.5M−86%−$15.9M−$4M−64%$23.1M−31%
−$12.6M+56%−$19.5M+231%$2.7M$1.9M$15.1M$32M$4.6M+69%$1.2M−37%−$658K−$2.7M−$34.7M$7.1M+500%
Net income$7.2M−$17.1M+10%−$39.5M+302%−$21.4M+116%−$33M−$23.8M+39%−$15.5M−61%$35.3M−$3.4M−90%−$15.7M−34%$30.1M$19.1M−46%
$0.30−$0.71+9%−$1.63+298%−$0.88+115%−$1.35−$0.97+37%−$0.63−61%$1.43−$0.14−90%−$0.64−34%$1.20$0.76−47%
24.4M+2%24.1M+1%24.2M+1%24.4M+1%24.4M+0%24.5M+2%24.5M+1%24.7M+1%24.7M+1%24.7M+1%25.2M+3%25M+1%

EPS, diluted: 12 periods, Q4 FY08 to Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: 13 periods, Q4 FY08 to Q4 FY21: share-days: the 12-month average less the 9-month, weighted by days. 5 periods, Q4 FY18 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Medical - Instruments & Supplies nearest ICU Medical's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
ICUIICU Medical$4.1B138×57.9×1.9×−9%1.4%
NVSTEnvista$4B42.6×28.0×1.4×+12%3.3%
BMIBadger Meter$4.5B36.4×47.6×5.1×−2%14.4%
VNTVontier$5B15.3×13.5×1.6×+1%11.3%
MMSIMerit Medical Systems$5.1B31.7×57.3×3.1×+9%9.9%
ATRCAtriCure$3B285×61.7×5.3×+14%1.9%
HAEHaemonetics$5.5B58.9×51.6×4.0×+0%7.1%
WRBYWarby Parker$2.9B341×359×3.2×+11%0.8%
MSAMSA Safety$7.2B23.2×36.2×3.7×+6%16.1%
UFPTUFP Technologies$2.2B30.6×25.6×3.5×+7%11.4%
INSPInspire Medical Systems$1.9B14.5×56.6×2.2×−0%15.0%
Peer median$4.2B34.1×49.6×3.4×+7%10.6%

More on ICU Medical

Each number over time

Its groups

About

Industry
Medical - Instruments & Supplies
Sector
Healthcare

Valuation data, not investment advice. Prices as of .